Aidan King, MBA, CFA

About

Aidan King is a Managing Partner and co-founder of Fountain Healthcare Partners. He is a pharmacist by training and began his career at Elan in pharmaceutical strategic marketing before moving to New York to work in Elan’s corporate venture capital group. He qualified as a pharmacist from Trinity College Dublin and in 1992 joined Elan Corporation’s strategic marketing group. In 1996, Aidan assumed Head of Strategic Marketing for Elan’s drug delivery division. Having completed an MBA at University College Dublin in 1998, Aidan moved to the U.S. as one of the founding members of Elan’s corporate venture capital group. Over the next five years, Aidan undertook over twenty strategic investments in public and private specialty pharma, biotechnology and medical device companies, in the U.S., Canada and Europe. In 2004, Aidan joined Bio-IB, a New York based boutique life science investment bank. Aidan is a CFA charter holder. He currently sits on the boards of Xylocor Therapeutics, Corteria Pharmaceuticals and Ermium Therapeutics. Previously, he was the firm’s representative on the boards of Syndesi Therapeutics (acquired by Abbvie, 2022), Civitas Therapeutics (acquired by Acorda, 2014), Chrono Therapeutics, Velicept Therapeutics and Palyon Medical. Aidan primarily focuses on US investments, marketing and fund raising.